Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome
- 1 January 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 84 (1), 94-100
- https://doi.org/10.1016/0002-9343(88)90014-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patientsAnnals of Neurology, 1986
- Revision of the Case Definition of Acquired Immunodeficiency Syndrome for National Reporting—United StatesAnnals of Internal Medicine, 1985
- New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin AAntimicrobial Agents and Chemotherapy, 1984
- Toxoplasma encephalitis in Haitian adults with acquired immunodeficiency syndrome: a clinical-pathologic-CT correlationAmerican Journal of Roentgenology, 1983
- OUTBREAK OF CENTRAL-NERVOUS-SYSTEM TOXOPLASMOSIS IN WESTERN EUROPE AND NORTH AMERICAThe Lancet, 1983
- The Effect of Trimethoprim and Sulfamethoxazole on Toxoplasma Gondii in Vitro and in Vivo *The American Journal of Tropical Medicine and Hygiene, 1979
- Treating toxoplasmosisJournal of Antimicrobial Chemotherapy, 1979
- A Comparative Study of Some Combined Treatment Regimens in Acute Toxoplasmosis in Mice *The American Journal of Tropical Medicine and Hygiene, 1978
- Toxoplasmosis in the Compromised HostAnnals of Internal Medicine, 1976
- Effect of Clindamycin on Acute and Chronic Toxoplasmosis in MiceAntimicrobial Agents and Chemotherapy, 1974